Skip to content
Shuttingdown

Nexalin Technology, Inc.

Electromedical & Electrotherapeutic Apparatus · HOUSTON · TX

Distress signal

Moderate confidence (50%)

Updated Oct 8, 2026, 12:04 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Nexalin Technology, Inc. received a delisting notice from its exchange (Sep 25, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Nexalin Technology, Inc. received a delisting notice from its exchange

    Sep 25, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously reported, on September 1, 2026, Nexalin Technology, Inc. (the Company ) presented its plan of compliance to the Hearings Panel (the Panel ) of The Nasdaq Stock Market LLC ( Nasdaq ) and requested continued listing on Nasdaq and an extension to demonstrate compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price Requirement ) and the minimum stockholders equity requirement of $2,500,000 for continued listing on The Nasd…”

  2. Nexalin Technology, Inc. received a delisting notice from its exchange

    Aug 14, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 14, 2026, Nexalin Technology, Inc. (the Company ) received a letter (the Letter ) from the Listing Qualifications Staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, based on the stockholders equity of $1,519,423 reported in the Company s Quarterly Report on Form 10-Q for the period ended June 30, 2026, the Company no longer satisfies the minimum stockholders equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Mar…”

  3. Nexalin Technology, Inc. received a delisting notice from its exchange

    Jul 24, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed on January 21, 2026, The Nasdaq Stock Market LLC ( Nasdaq ) notified Nexalin Technology, Inc. (the Company ) that the bid price of its common stock had closed at less than $1.00 per share over the previous 30 consecutive business days and, as a result, the Company did not comply with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market (the Minimum Bid Price Requirement ). In ac…”

  4. Nexalin Technology, Inc. received a delisting notice from its exchange

    Jan 21, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01. Notice of Delisting of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 21, 2026, Nexalin Technology, Inc. (the Company ) received a deficiency letter (the Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, based upon the closing bid price of the Company s common stock, par value $0.001per share ( Common Stock ), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for c…”

Company information

Founded
—
Employees (estimate)
—
Industry
Electromedical & Electrotherapeutic Apparatus
Subindustry
—
Listing
SEC lists the ticker NXL on Nasdaq.
SEC CIK
0001527352
Website
—
LinkedIn
—
Headquarters
HOUSTON, TX
Also known as
—
Legal entities
Nexalin Technology, Inc.

Sources

Every material source used to build this profile.

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously reported, on September 1, 2026, Nexalin Technology, Inc. (the Company ) presented its plan of compliance to the Hearings Panel (the Panel ) of The Nasdaq Stock Market LLC ( Nasdaq ) and requested continued listing on Nasdaq and an extension to demonstrate compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price Requirement ) and the minimum stockholders equity requirement of $2,500,000 for continued listing on The Nasd…
    View source record

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Nexalin Technology, Inc. — Electromedical & Electrotherapeutic Apparatus (SIC 3845) — HOUSTON, TX
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01. Notice of Delisting of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 21, 2026, Nexalin Technology, Inc. (the Company ) received a deficiency letter (the Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, based upon the closing bid price of the Company s common stock, par value $0.001per share ( Common Stock ), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for c…
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 14, 2026, Nexalin Technology, Inc. (the Company ) received a letter (the Letter ) from the Listing Qualifications Staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, based on the stockholders equity of $1,519,423 reported in the Company s Quarterly Report on Form 10-Q for the period ended June 30, 2026, the Company no longer satisfies the minimum stockholders equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Mar…
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed on January 21, 2026, The Nasdaq Stock Market LLC ( Nasdaq ) notified Nexalin Technology, Inc. (the Company ) that the bid price of its common stock had closed at less than $1.00 per share over the previous 30 consecutive business days and, as a result, the Company did not comply with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market (the Minimum Bid Price Requirement ). In ac…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:31 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:15 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:27 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.